15:18 IST
NSE
Management Change
Fortis Healthcare Management Change
Fortis Healthcare announced the appointment of Mr. Vijender Singh as MD and CEO of its subsidiary, Agilus Diagnostics, effective July 20, 2026.
Fortis Healthcare Ltd
- Share price
- ₹779.10
- Market cap
- ₹58,819 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 56.1×Sector 53.1×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 25.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Legal & Regulatory 4Other Announcement 3Management Change 3Financial Results 3Earnings Call 3Results Update 2Dividend 2Debt & Borrowing 2Board Meeting Outcome 2Annual General Meeting 2Partnership 1Merger & Restructuring 1Employee Stock Options 1Capacity Expansion 1Board Meeting Date 1
Time
3 announcements with these filters
11:04 IST
BSE
Management Change
Fortis Healthcare Management Change
Fortis Healthcare re‑appoints Dr. Ashutosh Raghuvanshi as CEO effective 19‑Mar‑2027 for a 24‑month term. The change was approved in the board meeting on 8‑Jul‑2026.
22:02 IST
NSE
Management Change
Fortis Healthcare Management Change
Fortis Healthcare Limited appointed M/s. Jitender, Navneet & Co. as Cost Auditors for a 12-month tenure. The experienced firm's appointment ensures statutory costing compliance.
- Execution
- 12 months